Completed NCT04134871
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Dundalk Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity, ... Behavioral Over 18 Years
Countries United Kingdom, Ireland
Sponsor University of Ulster
Condition Schizophrenia, Bipolarity, ... Withdrawn NCT00786318
This summary needs review. Please check the official study record and contact the research team for details.
In Washington D.C. Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 100 Years
Countries United States
Sponsor George Washington University
Condition Schizophrenia Completed NCT00125138
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Tucson Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance.
Countries United States, India, Italy
Sponsor Lundbeck LLC
Condition Schizophrenia Completed NCT00004826
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug
Countries
Sponsor Memorial Hospital of Rhode Island
Condition Schizophrenia Not recruiting ISRCTN98891022
This study is not recruiting in the United Kingdom. It focuses on Schizophrenia.
In United Kingdom Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other
Countries United Kingdom
Sponsor Kings College London (UK)
Condition Schizophrenia Completed NCT00780585
This study is completed. It is testing patients Who Participated for Schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug
Countries
Sponsor Merck Sharp & Dohme LLC
Condition Schizophrenia Completed NCT01518309
This study is completed in the United States. It is testing pimavanserin for Schizophrenia.
In Danbury Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug
Countries United States
Sponsor ACADIA Pharmaceuticals Inc.
Condition Schizophrenia Completed NCT02708940
This summary needs review. Please check the official study record and contact the research team for details.
In Los Angeles Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Depression, ... Behavioral
Countries United States
Sponsor University of California, Los Angeles
Condition Schizophrenia, Depression, ... Not recruiting ISRCTN12561259
This study is not recruiting in Canada. It focuses on Schizophrenia.
In Canada Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other Over 18 Years
Countries Canada
Sponsor Douglas Mental Health University Institute
Condition Schizophrenia Not recruiting ISRCTN43081021
This observational study is following people with severe mental illness to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
In United Kingdom Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity, ... Other Over 18 Years
Countries United Kingdom
Sponsor King's College London
Condition Schizophrenia, Bipolarity, ... Not recruiting ISRCTN62599190
This study is looking at whether This is an intention to treat, repeated measure within subjects randomised trial can help people with Schizophrenia, co-morbid drug and alcohol dependence, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program and complete follow-up questionnaires or assessments.
In United Kingdom Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Addiction Other Over 18 Years
Countries United Kingdom
Sponsor University College London (UK)
Condition Schizophrenia, Addiction Not recruiting ISRCTN12365070
This study is looking at whether a digital support tool can help people with Paranoid schizophrenia, Schizophrenic residual or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
In Germany Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other Over 18 Years
Countries Germany
Sponsor University of Augsburg
Condition Schizophrenia